CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 96 enrolled
Drug / intervention
Management algorithm for Malignant Bowel Obstructionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03260647
NCT03260647N/ACompleted
CompareCT.gov

Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction (MAMBO) Program for Women With Advanced Gynecological Cancers

University Health Network, Toronto·observational·Posted Aug 24, 2017·Updated Jun 22, 2025

In Brief

An observational study evaluating Management algorithm for Malignant Bowel Obstruction for Gynecologic Cancer. Completed, enrolled 96 participants across 1 site.

Detailed Summary

Management of Malignant Bowel Obstruction (MBO) in Patients with Advanced Gynecological Cancers

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGynecologic Cancer
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 24, 2017
Enrollment StartAug 4, 2017
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 7.4 yearsPosted 8.9 years ago

Interventions

Management algorithm for Malignant Bowel Obstructionother

a proposed management algorithm for MBO has been developed to provide a pathway that safeguards quality and continuity of care for patients under a multidisciplinary team. It will engage key-stakeholders and foster an inter-professional approach. It incorporates an in-patient management algorithm and a novel nursing-led ambulatory management algorithm to supplement patient's medical management